Strategy for randomised clinical trials in rare cancers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12842959.
- Also identified by PMC identifier 1126386.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proving that a new treatment is more effective than current treatment can be difficult for rare conditions. Data from small randomised trials could, however, be made more robust by taking other related research into account
Medical subject headings
- Neoplasms
- Randomized Controlled Trials as Topic
- Rare Diseases